Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression in the veal calf

Biochemical Pharmacology

Volumn 77, Issue 3, 2009, Pages 451-463

  Cantiello, Michela ^b   Giantin, Mery ^a   Carletti, Monica ^b   Lopparelli, Rosa M ^a   Capolongo, Francesca ^a   Lasserre, Frederic ^c   Bollo, Enrico ^b   Nebbia, Carlo ^b   Martin, Pascal G P ^c   Pineau, Thierry ^c   Dacasto, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CEMAGREF   (France)

Author keywords

Cattle; CYP3A; Dexamethasone; Illicit protocol; Liver; Nuclear receptors

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DESASHOCK; DEXAMETHASONE ISONICOTINATE; DEXAMETHASONE SODIUM PHOSPHATE; ENZYME; ERYTHROMYCIN N DEMETHYLASE; ETHYLMORPHINE N DEMETHYLASE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH; LIVER; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, NORTHERN; CATTLE; CYTOCHROME P-450 CYP3A; DEXAMETHASONE; GROWTH; LIVER; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 58349104813     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.10.025     Document Type: Article

References (77)

1. Schimmer B.P., and Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Harman J.G., Limbird L.E., and Goodman Gilman A. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics 1649 (2001), McGraw-Hill, New York 77
2. Yudt M.R., and Cidlowski J.A. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 16 (2002) 1719-1726
3. Sonneveld E., Jonas A., Meijer O.C., Brouwer A., and van der Burg B. Glucocorticoid-enhanced expression of dioxin target genes through regulation of the rat aryl hydrocarbon receptor. Toxicol Sci 99 (2007) 455-469
4. Pascussi J.-M., Gerbal-Chaloin S., Drocourt L., Maurel P., and Vilarem M.-J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619 (2003) 243-253
5. Galteau M.M., and Shamsa F. Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 59 (2003) 713-733
6. Gentile D.M., Tomlinson E.S., Maggs J.L., Kevin Park B., and Back D.J. Dexamethasone metabolism by human liver in vitro, metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther 277 (1996) 105-112
7. Burk O., and Wojnowski L. Cytochrome P450 3A and their regulation. Arch Pharmacol 369 (2004) 105-124
8. Luo G., Guenthner T., Gan L.-S., and Griffith Humphreys W. CYP3A induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 5 (2004) 483-505
9. Xu C., Li C.Y., and Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28 (2005) 249-268
10. Down M.J., Arkle S., and Mills J.J. Regulation and induction of CYP3A11, CYP3A13 and CYP3A13 and CYP3A25 in C57BL/6J mouse liver. Arch Biochem Biophys 457 (2007) 105-110
11. Duret C., Daujat-Chavanieu M., Pascussi J.-M., Pichard-Garcia L., Balaguer P., Fabre J.-M., et al. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol 70 (2006) 329-339
12. Gu X., Ke S., Liu D., Sheng T., Thomas P.E., Rabson A.B., et al. Role of NF-k{cyrillic}B in regulation of gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281 (2006) 17882-17889
13. Timsit Y.E., and Negishi M. CAR and PXR: the xenobiotic-sensing receptors. Steroids 72 (2007) 231-246
14. Zhou C., Tabb M.M., Nelson E.L., Grün F., Verma F., Sadatrafiei A., et al. Mutual repression between steroid and xenobiotic receptor and NF-k{cyrillic}B signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116 (2006) 2280-2289
15. Capolongo F., Tapparo M., Merlanti R., Ravarotto L., Tealdo E., Gallina G., et al. Illicit treatments in cattle and urinary 6beta-hydroxycortisol/cortisol ratio. Anal Chim Acta 586 (2006) 228-232
16. Zhang K., Kuroha M., Shibata Y., Kokue E., and Shimoda M. Effect of oral administration of clinically relevant doses of dexamethasone on regulation of cytochrome P450 subfamilies in hepatic microsomes from dogs and rats. Am J Vet Res 67 (2006) 329-334
17. Courtheyn D., Le Bizec B., Brambilla G., De Brabander H.F., Cobbaert E., Van de Wiel M., et al. Recent development in the use and abuse of growth promoters. Anal Chim Acta 473 (2002) 71-82
18. Abraham G., Gottschalk J., and Ungemach F.R. Possible role of dexamethasone in sensitizing the beta-2-adrenergic receptor system in vivo in calves during concomitant treatment with clenbuterol. Pharmacology 72 (2004) 196-204
19. Odore R., Badino P., Barbero R., Cuniberti B., Pagliasso S., Girardi C., et al. Regulation of β-adrenergic, glucocorticoid and androgen receptors induced by repeated exposure to growth promoters in male veal calves. Res Vet Sci 83 (2007) 227-233
20. Serratosa J., Blass A., Rigau B., Mongrell B., Rigau T., Tortadès M., et al. Residues from veterinary medicinal products, growth promoters and performance enhancers in food-producing animals: a European Union perspective. Rev Sci Tech OIE 25 (2006) 637-653
21. Plant N. The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction network. Biochim Biophys Acta 1770 (2007) 478-488
22. Dacasto M., Eeckhoutte C., Capolongo F., Dupuy J., Carletti M., Calleja C., et al. Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants. Vet Res 36 (2005) 179-190
23. Giantin M., Carletti M., Capolongo F., Pegolo S., Lopparelli R.M., Gusson F., et al. Effect of breed upon cytochrome P450s and phase II enzymes expression in cattle liver. Drug Metab Dispos 36 (2008) 1-9
24. Ioannides C. Cytochrome P450 expression in the liver of food-producing animals. Curr Drug Metab 7 (2006) 335-348
25. Machala M., Souček P., Neča J., Ulrich R., Lamka J., Szotáková B., et al. Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Arch Toxicol 77 (2003) 555-560
26. Natsuhori M., van Raak M., Ligtenberg M., Kleji L., ten Berge D., Zweers-Zeilmaker W.M., et al. Isolation of a bovine full length cytochrome P450 (CYP3A) cDNA sequence and its functional expression in V79 cells. Environ Toxicol Pharmacol 3 (1997) 17-24
27. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., and Carletti M. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. Vet J 165 (2003) 53-64
28. Sivapathasundaram S., Magnisali P., Coldham N.G., Howells L.C., Sauer M.J., and Ioannides C. A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and testosterone metabolism in bovine liver. Biochem Pharmacol 62 (2001) 635-645
29. Szotáková B., Baliharová V., Lamka J., Nožinová E., Wsól V., Velík J., et al. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res Vet Sci 76 (2004) 43-51
30. Greger D.L., Philipona C., and Blum J.W. Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domest Anim Endocrinol 31 (2006) 76-87
31. Krüger K.A., Blum J.W., and Greger D.L. Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. J Dairy Sci 88 (2005) 3971-3981
32. Lowry O., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
33. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
36. Diamondstone I.J. Assay of TAT activity by conversion of pHPP to pHBA. Anal Biochem 16 (1966) 395-401
37. Dundjerski J., Butorović B., Kipić J., Trajković D., and Matić G. Cadmium affects the activity of rat liver tyrosine aminotransferase and its induction by dexamethasone. Arch Toxicol 70 (1996) 390-395
38. Capolongo F., Merlanti R., Cibin V., De Liguoro M., and Montesissa C. In vivo hormone treatments in calves: effects on in vitro hydroxylation of testosterone. J Vet Pharmacol Ther 26 Suppl. 1 (2003) 159-160
39. Omura T., and Sato R. The carbon monoxide binding pigment of liver microsomes. II. Solubilisation, purification, properties. J Biol Chem 239 (1964) 2379-2385
40. Evans P.J. The regulation of hepatic tyrosine amino-transferase. Biochim Biophys Acta 677 (1981) 433-444
41. Jantzen H.M., Strahle U., Gloss B., Stewart F., Schmid W., Boshart M., et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49 (1987) 29-38
42. Ribarac-Stepić N., Vulović M., Korićanac G., and Isenović E. Basal and glucorticoid induced changes of hepatic glucorticoid receptor during aging: relation to activities of tyrosine aminotransferase and tryptophan oxygenase. Biogerontology 6 (2005) 113-131
43. Furuta T., Suzuki A., Mori C., Shibasaki H., Yokokawa A., and Kasuya Y. Evidence for the validity of cortisol 6β-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. Drug Metab Dispos 31 (2003) 1283-1287
44. Chen Z., Dunning L.A., Anderson K.E., Holtzman J.L., and Zheng W. Within-person variability of urinary 6β-hydroxycortisol to urinaryl ratios in Caucasian women. Steroids 69 (2004) 67-70
45. Sakuma T., Kitajima K., Nishiyama M., Endo Y., Miyauchi K., Jarukamjorn K., et al. Collaborated regulation of female-specific murine Cyp3a41 gene expression by growth and glucocorticoid hormones. Biochem Biophys Res Comm 314 (2004) 495-500
46. Sakuma T., Kitajima K., Nishiyama M., Mashino M., Hashita T., and Nemoto N. Suppression of female-specific Cyp2b9 gene expression by growth or glucocorticoid hormones. Biochem Biophys Res Comm 323 (2004) 776-781
47. 14C moxidectin by hepatic microsomes from various species. Vet Res Commun 25 (2001) 345-354
48. Zweers-Zeilmaker W.M., Van Miert A.S., Horbach G.J., and Witkamp R.F. In vitro complex formation and inhibition of cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. Res Vet Sci 66 (1999) 51-55
49. Nebbia C., Ceppa L., Dacasto M., Nachtmann C., and Carletti M. Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. J Vet Pharmacol Ther 24 (2001) 399-403
50. El Desoky E.S., Mohamed H.O., Farghaly W.M.A., Hamed S.A., Hedaya M.A., and Siest J.-P. Study of urinary 6β-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population. Pharmacol Res 51 (2005) 575-580
51. Romero D.G., Zhou M.-Y., and Gomez-Sanchez C.E. Cloning and expression of the bovine 11β-hydroxysteroid dehydrogenase type-2. J Steroid Mol Biol 72 (2000) 231-237
52. Caron E., Rioux N., Nicolas O., Lebel-Talbot H., and Hamelin B.A. Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR. J Biochem Mol Toxicol 19 (2005) 368-378
53. Adcock I.M. Molecular mechanisms of glucocorticoid actions. Pulm Pharmacol Ther 13 (2000) 115-123
54. El-Sankary W., Plant N.J., Gordon Gibson G., and Moore D.J. Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors. Drug Metab Dispos 28 (2000) 493-496
55. El-Sankary W., Bombail V., Gordon Gibson G., and Plant N. Glucocorticoid-mediated induction of CYP3A is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30 (2002) 1029-1034
56. Usui T., Saitoh Y., and Komada F. Induction of CYP3A in HepG2 cells by several drugs-association between induction of CYP3A and expression of glucocorticoid receptor. Biol Pharm Bull 26 (2003) 510-517
57. Pascussi J.-M., Drocourt L., Gerbal-Chaloin S., Fabre J.-M., Maurel P., and Vilarem M.-J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes, sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268 (2001) 6346-6358
58. Pascussi J.-M., Gerbal-Chaloin S., Drocourt L., Assénat E., Larrey D., Pichard-Garcia L., et al. Cross-talk between xenobiotic detoxification and other signalling pathways: clinical and toxicological consequences. Xenobiotica 34 (2004) 633-664
59. Pascussi J.-M., Gerbal-Chaloin S., Fabre J.-M., Maurel P., and Vilarem M.-J. Dexamethasone enhances constitutive androstan receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58 (2000) 1441-1450
60. Pascussi J.-M., Drocourt L., Fabre J.-M., Maurel P., and Vilarem M.-J. Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: synergistic increase of CYP3A induction by pregnane X receptor activators. Mol Pharmacol 58 (2000) 361-372
61. Pascussi J.-M., Busson-Le Coniat M., Maurel P., and Vilarem M.J. Transcriptional analysis of the orphan nuclear receptor constitutive androstan receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol 17 (2003) 42-55
62. Pascussi J.-M., Dvorák Z., Gerbal-Chaloin S., Assénat E., Maurel P., and Vilarem M.-J. Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 35 (2003) 255-268
63. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., and Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102 (1998) 1016-1023
64. Quattrochi L.C., and Guzelian P.S. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos 29 (2001) 615-622
65. Cole T.J., Blendy J.A., Monaghan A.P., Schmid W., Aguzzi A., and Schütz G. Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 60 (1995) 93-96
66. Nitsch D., Boshart M., and Schütz G. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc Natl Acad Sci U S A 90 (1993) 5479-5483
67. Dvořák Z., Modrianský M., Pichard-Garcia L., Balaguer P., Vilarem M.-J., Ulrichova J., et al. Colchicine down-regulates cytochrome P450 2B6, 2C9, and CYP3A4 in human hepatocytes by affecting their glucorticoid receptor-mediated regulation. Mol Pharmacol 64 (2003) 160-169
68. Greger D.L., and Blum W. Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calves. J Anim Physiol Anim Nutr 91 (2007) 62-67
69. Ekins S., Reschly E.J., Hagey L.R., and Krasowski M.D. Evolution of pharmacologic specificity of the pregnane X receptor. BMC Evol Biol 8 (2008) 103
70. Anakk S., Huang W., Staudinger J.L., Tan K., Cole T.J., Moore D.D., et al. Gender dictates the nuclear receptor-mediated regulation of CYP3A44. Drug Metab Dispos 35 (2007) 36-42
71. Cantiello M., Carletti M., Dacasto M., Pascal P.G.P., Pineau T., Capolongo F., et al. Cytochrome P450 inhibition profile in liver of veal calves administered a combination of 17β-estradiol, clenbuterol and dexamethsone for growth-promoting purposes. Food Chem Toxicol 46 (2008) 2849-2855
72. Huss J.M., Wang S.I., and Kasper C.B. Differential glucocorticoid responses of CYP3A23 and CYP3A2 are mediated by selective binding of orphan nuclear receptors. Arch Biochem Biophys 372 (1999) 321-332
73. van't Klooster G.A.E., Blaauboer B.J., Noordhoek J., and van Miert A.S.J.P.A.M. Cytochrome P450 induction and metabolism of alkoxyresorufins, ethylmorphine and testosterone in cultured hepatocytes from goats, sheep and cattle. Biochem Pharmacol 46 (1993) 1781-1790
74. Chen Y.-C., Gotzkowski S.K., Nafziger A.N., Kulawny R.W., Rocci Jr. M.L., Bertino Jr. J.S., et al. Poor correlation between 6β-hydroxycortisol:cortisol molar ratio and midazolam clearance as measure of hepatic CYP3A activity. Br J Clin Pharmacol 62 (2006) 187-195
75. Ohno M., Yamaguchi I., Ito T., Saiki K., Yamamoto I., and Azuma J. Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 55 (2000) 861-865
76. Tzeciak W.H., LeHoux J.-G., Waterman M.R., and Simpson E.R. Dexamethasone inhibits corticotrophin-induced accumulation of CYP11 and CYP17 mRNAs in bovine adrenocortial cells. Mol Endocrinol 7 (1993) 206-213
77. Vascellari M., Pozza G., Poppi L., Capello K., Angeletti R., Ravarotto L., et al. Evaluation of indirect biomarkers for detecting corticosteroids used as illegal growth promoters in beef cattle. Vet Rec 163 (2008) 147-151